Search

Author/Creator Niland, Brian

1. Assessment of risk of variant creutzfeldt‐Jakob disease (vCJD) from use of bovine heparin. Issue 5 (5th March 2020)

Authors:
Huang, Yin; Forshee, Richard A.; Keire, David; Lee, Sau; Gregori, Luisa; Asher, David M.; Bett, Cyrus; Niland, Brian; Brubaker, Scott A.; Anderson, Steven A.; Yang, Hong
Journal:
Pharmacoepidemiology and drug safety
Issue:
Volume 29:Issue 5(2020)
Page Start:
575
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluation. Issue 1 (29th May 2013)

Authors:
Vatsan, Ramjay S; Bross, Peter F; Liu, Ke; Theoret, Marc; De Claro, Angelo R; Lu, Jinhua; Helms, Whitney; Niland, Brian; Husain, Syed R; Puri, Raj K
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1:Issue 1(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Transaldolase haploinsufficiency in subjects with acetaminophen‐induced liver failure. Issue 3 (1st January 2020)

Authors:
Oaks, Zachary; Jimah, John; Grossman, Craig C.; Beckford, Miguel; Kelly, Ryan; Banerjee, Sanjay; Niland, Brian; Miklossy, Gabriella; Kuloglu, Zarife; Kansu, Aydan; Lee, William; Szonyi, Laszlo; Banki, Katalin; Perl, Andras
Journal:
Journal of inherited metabolic disease
Issue:
Volume 43:Issue 3(2020)
Page Start:
496
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗